Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Videos|March 9, 2022
Migraine-specific Preventive Therapies Can Be a Primary Care Tool, Leading Investigator Says
Author(s)Grace Halsey
Migraine-specific preventive therapies should be in the primary care toolbox, according to headache specialist Jessica Ailani, MD.
Advertisement
"These newer [migraine] therapies are geared for primary care. Their side effect profile is fantastic...they're easy to use...and primary care providers are very comfortable with monoclonal antibodies," said migraine specialist and researcher Jessica Ailani, MD, while speaking with Patient Care.
In the rest of our conversation, captured below, Ailani discussed the remarkable results some
Jessica Ailani, MD, is professor of clinical neurology and director of Medstar Georgetown Headache Center at the MedStar Georgetown University Hospital in Washington, DC.
Advertisement
Related to this article
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
2
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
3
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
4
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
5